Serratus Plane Block for Postoperative Pain Control

Summary

This is a randomized, double-blinded, placebo-controlled trial of serratus plane blocks in subjects undergoing outpatient unilateral or bilateral breast surgery. Ninety subjects will be enrolled into the study at presurgical testing. Subjects will be stratified based on surgery type and randomized to receive a serratus plane block with either bupivicaine HCL or placebo. All patients will receive standard intraoperative anesthesia and standard postoperative pain control. The primary endpoint is the amount of opioid administered postoperatively. Secondary endpoints include postoperative pain intensity at timed intervals, amount of opioid administered intraoperatively and postoperatively, incidence of nausea and vomiting, time to discharge and patient satisfaction

Timeline

Start

2017-09-05

Primary completion

2019-11-25

Completion

2019-11-25

Outcome

Outcome not reported

Stopped: “We decided to terminate this study due to staffing changes and other limitations posed by the COVID-19 pandemic.”

Drugs

Indications

No indication recorded.